Office-based Methadone Versus Buprenorphine to Address Retention in Medication for Opioid Use Disorder Treatment.
Status:
RECRUITING
Trial end date:
2029-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this clinical trial is to compare the effectiveness of office-based methadone with pharmacy administration and/or dispensing to office-based buprenorphine for the treatment of opioid use disorder. This study will also examine factors influencing the implementation of office-based methadone.
Phase:
PHASE4
Details
Lead Sponsor:
Yale University
Collaborators:
Alameda Health System Boston Medical Center (BMC) Hennepin Healthcare Research Institute Kaiser Permanente Marshall Health National Institute on Drug Abuse (NIDA) National Institutes of Health (NIH) The Emmes Company, LLC University of California, San Francisco